Abstract
In this matched cohort study, clinical data from 43 paediatric cancer patients with bloodstream infection (BSI) were compared with 43 thoroughly matched control patients without BSI. BSI led to a median additional length of inpatient treatment of 12 days (IQR 8.5-16 days; P<0.001), accounting for median additional expenses of euro4400 (IQR, euro3145-5920) per case [6.970 US Dollar (IQR 4.938-9.294)]. Thus, BSI substantially increased financial resources required for inpatient treatment. These data compiled from a paediatric cancer unit may be utilized to estimate the cost-benefit ratio of targeted preventive measures.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Bacteremia / complications
-
Bacteremia / economics*
-
Bacteremia / microbiology
-
Cancer Care Facilities / economics
-
Case-Control Studies
-
Catheter-Related Infections / complications
-
Catheter-Related Infections / economics*
-
Catheter-Related Infections / microbiology
-
Catheters, Indwelling / microbiology
-
Child
-
Child, Preschool
-
Cohort Studies
-
Costs and Cost Analysis
-
Cross Infection / complications
-
Cross Infection / economics*
-
Cross Infection / microbiology
-
Female
-
Germany
-
Hospitalization / economics
-
Hospitals, Pediatric / economics*
-
Humans
-
Infant
-
Length of Stay / economics*
-
Male
-
Neoplasms / complications*